{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-005398","form_type":"8-K","ticker":"FBLG","cik":"0001958777","company_name":"FibroBiologics, Inc.","filed_at":"2024-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.374973+00:00","generated_at":"2026-06-06T05:57:27.346132+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"FibroBiologics announces three US patents for fibroblast technology","bullets":["Patent 11,717,596 (Sevrain): Methods for cartilage repair using in vivo bioreactor.","Patent 11,732,239 (O'Heeron): Treatment of disc degenerative disease with fibroblast conditioned media.","Patent 11,819,555 (O'Heeron): Gene therapy for regeneration of chondrocytes or cartilage-type cells.","Company now holds 150+ patents issued and pending, reinforcing its IP portfolio."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-005398","json":"https://secwatch.observer/filing/0001493152-24-005398.json","markdown":"https://secwatch.observer/filing/0001493152-24-005398.md","text":"https://secwatch.observer/filing/0001493152-24-005398.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958777/000149315224005398/0001493152-24-005398-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958777/000149315224005398/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T05:57:27.346132+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}